Related Experiment Videos
125I eye plaque dose distribution including penumbra characteristics
A de la Zerda1, S T Chiu-Tsao, J Lin
1Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan 48202, USA.
Medical Physics
|March 1, 1996
Summary
This study quantifies dose distribution for Iodine-125 eye plaques, revealing significant dose reduction due to plaque and air interfaces. Findings aid in developing treatment planning algorithms for ophthalmic radiotherapy.
Area of Science:
- Medical Physics
- Radiation Oncology
- Ophthalmology
Background:
- Accurate dose calculation is crucial for effective and safe ophthalmic radiotherapy using Iodine-125 (125I) eye plaques.
- Understanding the interplay between the plaque, the eye-air interface, and dose distribution is essential for treatment planning.
Purpose of the Study:
- To determine penumbra characteristics for 125I eye plaques.
- To assess the influence of the plaque and eye-air interface on dose distribution.
- To initiate the development of a treatment planning algorithm for clinical dose calculations.
Main Methods:
- Dose measurements were performed in a solid water eye phantom using 125I (6711) seeds in a 20 mm COMS eye plaque.
- Thermoluminescent dosimeters (TLD) cubes and minichips were used inside and outside the phantom in longitudinal and transverse planes.
- Analytic fitting of measured data (Dr2) was conducted using double exponential and modified Fermi-Dirac functions.
Main Results:
- The combined plaque and eye-air interface reduced central axis dose by up to 20% at 2.5 cm.
- Dose reduction was more pronounced at larger off-axis coordinates.
- The plaque alone caused a 7% dose reduction at 2.5 cm; the eye-air interface contributed an additional 13% reduction.
Conclusions:
- The eye-air interface significantly impacts dose distribution, primarily by reducing backscatter.
- Penumbra characteristics were quantified, showing depth-dependent variations.
- Developed analytic functions provide a basis for clinical treatment planning algorithms for 125I eye plaque brachytherapy.